An efficient system for intracellular delivery of beta-lactam antibiotics to overcome bacterial resistance
Open Access
- 27 August 2015
- journal article
- Published by Springer Science and Business Media LLC in Scientific Reports
- Vol. 5 (1), 13500
- https://doi.org/10.1038/srep13500
Abstract
The “Golden era” of antibiotics is definitely an old story and this is especially true for intracellular bacterial infections. The poor intracellular bioavailability of antibiotics reduces the efficency of many treatments and thereby promotes resistances. Therefore, the development of nanodevices coupled with antibiotics that are capable of targeting and releasing the drug into the infected-cells appears to be a promising solution to circumvent these complications. Here, we took advantage of two natural terpenes (farnesyl and geranyl) to design nanodevices for an efficient intracellular delivery of penicillin G. The covalent linkage between the terpene moieties and the antibiotic leads to formation of prodrugs that self-assemble to form nanoparticles with a high drug payload between 55–63%. Futhermore, the addition of an environmentally-sensitive bond between the antibiotic and the terpene led to an efficient antibacterial activity against the intracellular pathogen Staphylococcus aureus with reduced intracellular replication of about 99.9% compared to untreated infected cells. Using HPLC analysis, we demonstrated and quantified the intracellular release of PenG when this sensitive-bond (SB) was present on the prodrug, showing the success of this technology to deliver antibiotics directly into cells.This publication has 41 references indexed in Scilit:
- RpoS Plays a Central Role in the SOS Induction by Sub-Lethal Aminoglycoside Concentrations in Vibrio choleraePLoS Genetics, 2013
- Polylactide-co-glycolide-rifampicin-nanoparticles efficiently clearMycobacterium bovisBCG infection in macrophages and remain membrane-bound in phago-lysosomesJournal of Cell Science, 2013
- Cellular pharmacokinetics and intracellular activity against Listeria monocytogenes and Staphylococcus aureus of chemically modified and nanoencapsulated gentamicinJournal of Antimicrobial Chemotherapy, 2012
- Lipase-Sensitive Polymeric Triple-Layered Nanogel for “On-Demand” Drug DeliveryJournal of the American Chemical Society, 2012
- Targeted delivery of antibiotics to intracellular chlamydial infections using PLGA nanoparticlesBiomaterials, 2011
- Cooperation between Prokaryotic (Lde) and Eukaryotic (MRP) Efflux Transporters in J774 Macrophages Infected withListeria monocytogenes: Studies with Ciprofloxacin and MoxifloxacinAntimicrobial Agents and Chemotherapy, 2008
- A Potential New Pathway for Staphylococcus aureus Dissemination: The Silent Survival of S. aureus Phagocytosed by Human Monocyte-Derived MacrophagesPLOS ONE, 2008
- Early Bactericidal Activity of High-Dose Rifampin in Patients with Pulmonary Tuberculosis Evidenced by Positive Sputum SmearsAntimicrobial Agents and Chemotherapy, 2007
- Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infectionsNature Reviews Microbiology, 2006
- Intracellular distribution and activity of antibioticsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991